This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2017-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2024
Title: Kenneth Joseph Fraunhoffer: Innovator in Pharmaceutical Chemistry
Introduction
Kenneth Joseph Fraunhoffer is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of three patents. His work focuses on the development of innovative compounds and methods that have the potential to impact various therapeutic areas.
Latest Patents
Fraunhoffer's latest patents include the invention of substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation. The disclosures are directed to enhanced methods for preparing these specific compounds, showcasing his commitment to advancing pharmaceutical science.
Career Highlights
Fraunhoffer is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role at the company allows him to leverage his expertise in drug development and contribute to the creation of new therapeutic solutions.
Collaborations
Throughout his career, Fraunhoffer has collaborated with esteemed colleagues, including Albert J. Delmonte and Benjamin Cohen. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Kenneth Joseph Fraunhoffer's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new therapeutic compounds and methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile